首页 > 最新文献

Advances in Medical, Dental and Health Sciences最新文献

英文 中文
Qualitative and Quantitative Standardization of Andrographis paniculata by TLC Technique and UV Method 薄层色谱法和紫外分光光度法对穿心莲的定性定量标准
Pub Date : 2019-10-09 DOI: 10.5530/amdhs.2019.3.9
J. Ahamad, M. Ameen, E. T. Anwer, Subasini Uthirapathy, O. Porwal
Background: Andrographis paniculata Wall. commonly known as Kalmegh and widely used for the treatment of the liver complications in Indian sub-continent. It is important ingredient of several traditional herbal formulations. Materials and Methods: Hence we planned to developed quick qualitative and quantitative standardization method for its quality control by using TLC and UV-visible spectroscopic methods for its better therapeutic efficacy. Results: TLC and UV-visible spectroscopic method has been developed for identification and quantification of andrographolide in A. paniculata herb samples. The developed TLC resulted in well resolved spots of different constituents of herb along with andrographolide standard. The developed UV-visible spectroscopic method was used for the estimation of andrographolide in A. paniculata herb samples. Conclusions: These quick standardization methods are used as analytical tool for the routine analysis of A. paniculata herb samples for achieving better therapeutic effects.
背景:穿心莲。通常被称为Kalmegh,广泛用于治疗印度次大陆的肝脏并发症。它是几种传统草药配方的重要成分。材料与方法:为了使其具有更好的治疗效果,我们计划采用薄层色谱法和紫外可见光谱法,建立快速定性定量的标准化方法来控制其质量。结果:建立了薄层色谱法和紫外可见光谱法对穿心莲药材中穿心莲内酯的鉴别定量方法。建立的薄层色谱法在穿心莲内酯标准品的基础上,对药材的不同成分进行了较好的鉴别。采用紫外可见分光光度法测定穿心莲药材中穿心莲内酯的含量。结论:这些快速标准化方法可作为中药标本常规分析的分析工具,具有较好的疗效。
{"title":"Qualitative and Quantitative Standardization of Andrographis paniculata by TLC Technique and UV Method","authors":"J. Ahamad, M. Ameen, E. T. Anwer, Subasini Uthirapathy, O. Porwal","doi":"10.5530/amdhs.2019.3.9","DOIUrl":"https://doi.org/10.5530/amdhs.2019.3.9","url":null,"abstract":"Background: Andrographis paniculata Wall. commonly known as Kalmegh and widely used for the treatment of the liver complications in Indian sub-continent. It is important ingredient of several traditional herbal formulations. Materials and Methods: Hence we planned to developed quick qualitative and quantitative standardization method for its quality control by using TLC and UV-visible spectroscopic methods for its better therapeutic efficacy. Results: TLC and UV-visible spectroscopic method has been developed for identification and quantification of andrographolide in A. paniculata herb samples. The developed TLC resulted in well resolved spots of different constituents of herb along with andrographolide standard. The developed UV-visible spectroscopic method was used for the estimation of andrographolide in A. paniculata herb samples. Conclusions: These quick standardization methods are used as analytical tool for the routine analysis of A. paniculata herb samples for achieving better therapeutic effects.","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128826853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Analysis of Fine Needle Aspiration Cytology in Diagnosing the Patients with Breast Lump: A Prospective Study 细针穿刺细胞学诊断乳腺肿块的前瞻性研究
Pub Date : 2019-06-25 DOI: 10.5530/AMDHS.2019.2.7
Ushasree Adepu, Harinandani Appam, Brahmani Bachu, Avinassh Tippani, S. Anchuri
{"title":"Analysis of Fine Needle Aspiration Cytology in Diagnosing the Patients with Breast Lump: A Prospective Study","authors":"Ushasree Adepu, Harinandani Appam, Brahmani Bachu, Avinassh Tippani, S. Anchuri","doi":"10.5530/AMDHS.2019.2.7","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.2.7","url":null,"abstract":"","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115268847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparision of 10% Nitric Acid, Edta and 10% Formic Acid for Tooth Decalcification 10%硝酸、Edta和10%甲酸对牙齿脱钙效果的比较
Pub Date : 2019-06-25 DOI: 10.5530/AMDHS.2019.2.8
Nitish Bhat, K. Thakur, Nandini Bharadwaj, Ramandeep Singh
Decalcification of hard tissues has remained an important part in visualizing the histology of the section. For the process of decalcification various decalcifying agents have been used in the past but very limited studies can be found in the literature about the comparison of various decalcifying agents. Aim: Here we present a study comparing three different decalcifying agents (10% Nitric acid, EDTA, 10 % Formic acid). Methodology: 30 freshly extracted premolars were decalcified using three different decalcifying agents. The end point of decalcification was tested by chemical methods. The decalcified sections were routinely processed and staining was done using Hematoxylin and Eosin. Result: Sections decalcified with EDTA gave better results as compared to the other two groups. Conclusion: EDTA is a better option for decalcification of tooth but it has a slow rate of action. So, for the cases requiring urgent results nitric acid can be used.
硬组织的脱钙仍然是可视化切片组织学的重要组成部分。对于脱钙过程,过去已经使用了各种脱钙剂,但文献中对各种脱钙剂的比较研究非常有限。目的:本研究比较了三种不同的脱钙剂(10%硝酸、EDTA、10%甲酸)。方法:采用三种不同的脱钙剂对30颗新拔牙进行脱钙。用化学方法测定了脱钙终点。脱钙切片常规处理,苏木精和伊红染色。结果:EDTA脱钙切片效果优于其他两组。结论:EDTA是治疗牙齿脱钙的较好选择,但作用速度慢。因此,对于需要紧急结果的病例,可以使用硝酸。
{"title":"Comparision of 10% Nitric Acid, Edta and 10% Formic Acid for Tooth Decalcification","authors":"Nitish Bhat, K. Thakur, Nandini Bharadwaj, Ramandeep Singh","doi":"10.5530/AMDHS.2019.2.8","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.2.8","url":null,"abstract":"Decalcification of hard tissues has remained an important part in visualizing the histology of the section. For the process of decalcification various decalcifying agents have been used in the past but very limited studies can be found in the literature about the comparison of various decalcifying agents. Aim: Here we present a study comparing three different decalcifying agents (10% Nitric acid, EDTA, 10 % Formic acid). Methodology: 30 freshly extracted premolars were decalcified using three different decalcifying agents. The end point of decalcification was tested by chemical methods. The decalcified sections were routinely processed and staining was done using Hematoxylin and Eosin. Result: Sections decalcified with EDTA gave better results as compared to the other two groups. Conclusion: EDTA is a better option for decalcification of tooth but it has a slow rate of action. So, for the cases requiring urgent results nitric acid can be used.","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120979406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Malaria Elimination Research Alliance (MERA) - The Launch of a Milestone 消除疟疾研究联盟(MERA)——里程碑式的启动
Pub Date : 2019-06-25 DOI: 10.5530/AMDHS.2019.2.5
S. Hossain
{"title":"Malaria Elimination Research Alliance (MERA) - The Launch of a Milestone","authors":"S. Hossain","doi":"10.5530/AMDHS.2019.2.5","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.2.5","url":null,"abstract":"","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128238393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comprehensive Review on Selected Traditional Herbs in the Treatment of Metabolic Syndrome 中药选材治疗代谢综合征综合综述
Pub Date : 2019-06-25 DOI: 10.5530/AMDHS.2019.2.6
J. Ahamad
{"title":"A Comprehensive Review on Selected Traditional Herbs in the Treatment of Metabolic Syndrome","authors":"J. Ahamad","doi":"10.5530/AMDHS.2019.2.6","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.2.6","url":null,"abstract":"","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114519556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency, Prognosis and Risk Factors of Congestive Heart Failure in Dialysis Patients Attending Public Hospitals in Pakistan 巴基斯坦公立医院透析患者充血性心力衰竭的发生频率、预后及危险因素
Pub Date : 2019-05-01 DOI: 10.5530/AMDHS.2019.1.4
Fazal ur Rehman Khilji, Q. Iqbal, S. Haider, Muhammad Anwar, A. Khalid, Fazal Muhammad, A. Zarkoon, F. Saleem
Introduction: Congestive Heart Failure (CHF) in patients with dialysis is a concern increasing morbidity and mortality. Research was conducted to evaluate CHF in dialysis patients; it`s frequency and prognosis among patients attending public healthcare institutions in Pakistan. Methods: This was a multicenter cohort study whereby data of 117 patients for one year was evaluated retrospectively. Results: All patients had End-Stage Renal Disease (ESRD) and were on regular maintenance hemodialysis therapy. 7.7 % patients had Non-Insulin Dependent Diabetes Mellitus, 4.3% had Ischemic Heart Disease, 78.6% had Left Ventricular Hypertrophy and 80.34% had Cardiomyopathy. 38.5% were confirmed with CHF. 31.6% had systolic dysfunction, 6.8% had diastolic dysfunction and 3.4% had both systolic and diastolic dysfunction. Among patients with systolic dysfunction, 2.6% measured Left Ejection Ventricle Fraction (LEVF) of ≤ 20%, 13.7% measured 21-30% and 15.4% measured 3-40%. Additionally, 28.9% developed de novo CHF. Recurrence of CHF was observed in 57.7% and mortality rate was 24% in CHF group. Conclusion: Incidence of CHF was relatively high in these patients. Frequent recurrence of the disease, re-hospitalization and enhanced mortality is evident of adverse prognosis of CHF in ESRD patients. CVD must not be considered separately in ESRD patients. Appropriate management and correction of risk factors of co-morbid conditions can be helpful in improving the disease condition..
简介:充血性心力衰竭(CHF)在透析患者是一个令人关注的发病率和死亡率增加。研究评估透析患者的CHF;在巴基斯坦公立医疗机构就诊的患者中,它的发病率和预后。方法:这是一项多中心队列研究,回顾性评估117例患者一年的数据。结果:所有患者均为终末期肾病(ESRD),并接受常规维持性血液透析治疗。非胰岛素依赖型糖尿病7.7%,缺血性心脏病4.3%,左室肥厚78.6%,心肌病80.34%,确诊CHF 38.5%。31.6%有收缩期功能障碍,6.8%有舒张期功能障碍,3.4%有收缩期和舒张期功能障碍。在收缩功能障碍患者中,2.6%的患者左射血心室分数(LEVF)≤20%,13.7%的患者为21-30%,15.4%的患者为3-40%。此外,28.9%的患者发展为新发CHF。CHF组复发率为57.7%,病死率为24%。结论:本组患者CHF发病率较高。频繁的疾病复发、再次住院和死亡率的提高是ESRD患者CHF不良预后的明显因素。在ESRD患者中不应单独考虑CVD。对合并症的危险因素进行适当的管理和纠正有助于改善病情。
{"title":"Frequency, Prognosis and Risk Factors of Congestive Heart Failure in Dialysis Patients Attending Public Hospitals in Pakistan","authors":"Fazal ur Rehman Khilji, Q. Iqbal, S. Haider, Muhammad Anwar, A. Khalid, Fazal Muhammad, A. Zarkoon, F. Saleem","doi":"10.5530/AMDHS.2019.1.4","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.1.4","url":null,"abstract":"Introduction: Congestive Heart Failure (CHF) in patients with dialysis is a concern increasing morbidity and mortality. Research was conducted to evaluate CHF in dialysis patients; it`s frequency and prognosis among patients attending public healthcare institutions in Pakistan. Methods: This was a multicenter cohort study whereby data of 117 patients for one year was evaluated retrospectively. Results: All patients had End-Stage Renal Disease (ESRD) and were on regular maintenance hemodialysis therapy. 7.7 % patients had Non-Insulin Dependent Diabetes Mellitus, 4.3% had Ischemic Heart Disease, 78.6% had Left Ventricular Hypertrophy and 80.34% had Cardiomyopathy. 38.5% were confirmed with CHF. 31.6% had systolic dysfunction, 6.8% had diastolic dysfunction and 3.4% had both systolic and diastolic dysfunction. Among patients with systolic dysfunction, 2.6% measured Left Ejection Ventricle Fraction (LEVF) of ≤ 20%, 13.7% measured 21-30% and 15.4% measured 3-40%. Additionally, 28.9% developed de novo CHF. Recurrence of CHF was observed in 57.7% and mortality rate was 24% in CHF group. Conclusion: Incidence of CHF was relatively high in these patients. Frequent recurrence of the disease, re-hospitalization and enhanced mortality is evident of adverse prognosis of CHF in ESRD patients. CVD must not be considered separately in ESRD patients. Appropriate management and correction of risk factors of co-morbid conditions can be helpful in improving the disease condition..","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126784359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erectile Dysfunction: An Update 勃起功能障碍:最新进展
Pub Date : 2019-05-01 DOI: 10.5530/AMDHS.2019.1.3
Saurabh Nimesh, R. Tomar, Manoj Kumar, Nitish Tyagi, P. Shukla
Erectile dysfunction or Sexual dysfunction or male impotence is defined as the inability of a man to achieve and maintain an erection sufficient for mutually satisfactory intercourse with his partner. Sexual health and function are important determinants of quality of life. ED is a significant and common medical problem. An estimated 150 million men worldwide have some degree of ED, and more than twice that many are expected to be affected by 2025. Several orally active drugs Apomorphine sublingual, Sildenafil, Vardenafil, Tadalafil and Avanafil are currently prescribed for the treatment of ED to improve the arterial blood flow to the penile tissue. Herbal medicinal plants and their extracts have been used in traditional medicine in treatment of ED. These herbal medicinal drugs are including Ginseng, Ashwagandha, Yohimbine, Safed musli, Shilajit, Ginkgo. The present review provides an overview of the knowledge of ED or sexual dysfunction at the time.
勃起功能障碍或性功能障碍或男性阳痿被定义为男性无法达到和维持足以与伴侣进行相互满意的性交的勃起。性健康和性功能是生活质量的重要决定因素。ED是一个重要而常见的医学问题。据估计,全球有1.5亿男性患有不同程度的ED,预计到2025年,这一数字将增加一倍以上。目前用于治疗ED的口服活性药物有阿波啡、西地那非、伐地那非、他达拉非和阿瓦那非,以改善阴茎组织的动脉血流。草药植物及其提取物在传统医学中用于治疗ED。这些草药包括人参,阿什瓦甘达,育亨宾,沙法木,希拉吉特,银杏。本文综述了当时ED或性功能障碍的相关知识。
{"title":"Erectile Dysfunction: An Update","authors":"Saurabh Nimesh, R. Tomar, Manoj Kumar, Nitish Tyagi, P. Shukla","doi":"10.5530/AMDHS.2019.1.3","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.1.3","url":null,"abstract":"Erectile dysfunction or Sexual dysfunction or male impotence is defined as the inability of a man to achieve and maintain an erection sufficient for mutually satisfactory intercourse with his partner. Sexual health and function are important determinants of quality of life. ED is a significant and common medical problem. An estimated 150 million men worldwide have some degree of ED, and more than twice that many are expected to be affected by 2025. Several orally active drugs Apomorphine sublingual, Sildenafil, Vardenafil, Tadalafil and Avanafil are currently prescribed for the treatment of ED to improve the arterial blood flow to the penile tissue. Herbal medicinal plants and their extracts have been used in traditional medicine in treatment of ED. These herbal medicinal drugs are including Ginseng, Ashwagandha, Yohimbine, Safed musli, Shilajit, Ginkgo. The present review provides an overview of the knowledge of ED or sexual dysfunction at the time.","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126271686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer- I am and I will 巨蟹座-我是,我将是
Pub Date : 2019-05-01 DOI: 10.5530/AMDHS.2019.1.2
S. Hossain
{"title":"Cancer- I am and I will","authors":"S. Hossain","doi":"10.5530/AMDHS.2019.1.2","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.1.2","url":null,"abstract":"","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"108 ","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114090421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy Informatics: An Emerging Field 药学信息学:一个新兴领域
Pub Date : 2019-05-01 DOI: 10.5530/AMDHS.2019.1.1
S. Atique, Chien-Yeh Hsu
{"title":"Pharmacy Informatics: An Emerging Field","authors":"S. Atique, Chien-Yeh Hsu","doi":"10.5530/AMDHS.2019.1.1","DOIUrl":"https://doi.org/10.5530/AMDHS.2019.1.1","url":null,"abstract":"","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124491206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Survey of Drug Information Centers Practice: Research and Publication System at Ministry of Health Hospitals in Saudi Arabia 全国药品信息中心实践调查:沙特阿拉伯卫生部医院的研究和出版系统
Pub Date : 2018-12-30 DOI: 10.5530/amdhs.2018.1.5
Y. Alomi, S. Alghamdi, R. A. Alattyh
Objective: To explore the National Survey of Drug Information Centers practice in Saudi Arabia: Research and Publications at MOH hospitals. Methods: It is a cross-sectional four months national survey of Drug Information Services at MOH. It contained ten domains with 181 questions designed by the authors. It was derived from Internal Pharmaceutical Federation, American Society of Health-System Pharmacists best practice guidelines. This survey was distributed to forty hospital pharmacies that run drug information services. In this study, the domain Research and Publications System was explored and analyzed. It consisted of eight questions about the written policy and procedure and application methods for Research and Publications at MOH system in the drug information centers. All analysis was done through survey monkey system. Results: The survey was distributed to 45 of hospitals, the response rate, was 40 (88.88%) hospitals. The highest score of investigational drug services was a written policy and procedure for IDS did not exist in 23 (57.5%) hospitals while only 6 (15%) of hospitals 100% applied the elements. The highest score of Pharmacy Professional Publications Services was the written policy and procedure for Professional Publications Services did not exist in 24 (60%) hospitals while only 6 (15%) of hospitals 100% applied the elements. The highest scores of Pharmacy Ethical and Legal Issues was a Written policy and procedure for Pharmacy Ethical and Legal did not exist in 20 (50%) hospitals while only 7 (17.5%) of hospitals 100% applied the elements. Conclusion: There was a weak implementation of Research and Publications system in drug information centers practice. An educating and training of drug information pharmacist on the Research and Publications system is required.in addition to setup up policy and procedures during the implementation of the services.
目的:探讨沙特阿拉伯药品信息中心实践的全国调查:卫生部医院的研究和出版物。方法:对卫生部药品信息服务部门进行为期4个月的全国横断面调查。它包含十个领域,由作者设计的181个问题。它来源于内部药物联合会,美国卫生系统药剂师协会最佳实践指南。本调查向40家提供药品信息服务的医院药房发放。本研究对领域研究与出版系统进行了探索与分析。包括8个问题,内容涉及卫生部系统在药品信息中心的研究和出版物的书面政策和程序以及申请方法。所有的分析都是通过调查猴子系统完成的。结果:共发放调查问卷45家医院,回复率为40家(88.88%)医院。在临床试验药品服务方面得分最高的是23家(57.5%)医院没有IDS的书面政策和程序,只有6家(15%)医院100%应用了这些要素。“药学专业出版服务”得分最高的是24家(60%)医院没有专业出版服务的书面政策和程序,只有6家(15%)医院100%应用了这些要素。“药学伦理与法律问题”得分最高的是20家(50%)医院没有“药学伦理与法律的书面政策和程序”,只有7家(17.5%)医院100%应用了这些要素。结论:在药品信息中心实践中,研究与发表制度的执行力度较弱。需要对药品信息药师进行研究和出版系统的教育和培训。除了在服务实施期间建立政策和程序之外。
{"title":"National Survey of Drug Information Centers Practice: Research and Publication System at Ministry of Health Hospitals in Saudi Arabia","authors":"Y. Alomi, S. Alghamdi, R. A. Alattyh","doi":"10.5530/amdhs.2018.1.5","DOIUrl":"https://doi.org/10.5530/amdhs.2018.1.5","url":null,"abstract":"Objective: To explore the National Survey of Drug Information Centers practice in Saudi Arabia: Research and Publications at MOH hospitals. Methods: It is a cross-sectional four months national survey of Drug Information Services at MOH. It contained ten domains with 181 questions designed by the authors. It was derived from Internal Pharmaceutical Federation, American Society of Health-System Pharmacists best practice guidelines. This survey was distributed to forty hospital pharmacies that run drug information services. In this study, the domain Research and Publications System was explored and analyzed. It consisted of eight questions about the written policy and procedure and application methods for Research and Publications at MOH system in the drug information centers. All analysis was done through survey monkey system. Results: The survey was distributed to 45 of hospitals, the response rate, was 40 (88.88%) hospitals. The highest score of investigational drug services was a written policy and procedure for IDS did not exist in 23 (57.5%) hospitals while only 6 (15%) of hospitals 100% applied the elements. The highest score of Pharmacy Professional Publications Services was the written policy and procedure for Professional Publications Services did not exist in 24 (60%) hospitals while only 6 (15%) of hospitals 100% applied the elements. The highest scores of Pharmacy Ethical and Legal Issues was a Written policy and procedure for Pharmacy Ethical and Legal did not exist in 20 (50%) hospitals while only 7 (17.5%) of hospitals 100% applied the elements. Conclusion: There was a weak implementation of Research and Publications system in drug information centers practice. An educating and training of drug information pharmacist on the Research and Publications system is required.in addition to setup up policy and procedures during the implementation of the services.","PeriodicalId":237766,"journal":{"name":"Advances in Medical, Dental and Health Sciences","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123713103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Advances in Medical, Dental and Health Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1